Free Trial

Allurion Technologies (ALUR) Competitors

Allurion Technologies logo
$1.98 -0.01 (-0.45%)
As of 09:39 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ALUR vs. QTI, DXR, ICCM, MDAI, TELA, CTSO, NEPH, BDMD, SURG, and SRTS

Should you be buying Allurion Technologies stock or one of its competitors? The main competitors of Allurion Technologies include QT Imaging (QTI), Daxor (DXR), IceCure Medical (ICCM), Spectral AI (MDAI), TELA Bio (TELA), Cytosorbents (CTSO), Nephros (NEPH), Baird Medical Investment (BDMD), SurgePays (SURG), and Sensus Healthcare (SRTS). These companies are all part of the "medical equipment" industry.

Allurion Technologies vs. Its Competitors

Allurion Technologies (NYSE:ALUR) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, media sentiment, earnings, profitability and institutional ownership.

Allurion Technologies has a beta of -0.45, meaning that its stock price is 145% less volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.2, meaning that its stock price is 120% less volatile than the S&P 500.

QT Imaging has a net margin of 0.00% compared to Allurion Technologies' net margin of -158.30%.

Company Net Margins Return on Equity Return on Assets
Allurion Technologies-158.30% N/A -59.91%
QT Imaging N/A N/A -65.94%

Allurion Technologies presently has a consensus target price of $9.25, suggesting a potential upside of 366.94%. Given Allurion Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Allurion Technologies is more favorable than QT Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Allurion Technologies
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
QT Imaging
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

21.4% of Allurion Technologies shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 9.6% of Allurion Technologies shares are held by insiders. Comparatively, 75.4% of QT Imaging shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, QT Imaging had 1 more articles in the media than Allurion Technologies. MarketBeat recorded 1 mentions for QT Imaging and 0 mentions for Allurion Technologies. QT Imaging's average media sentiment score of 1.42 beat Allurion Technologies' score of 0.00 indicating that QT Imaging is being referred to more favorably in the news media.

Company Overall Sentiment
Allurion Technologies Neutral
QT Imaging Positive

QT Imaging has lower revenue, but higher earnings than Allurion Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Allurion Technologies$32.11M0.48-$7.20M-$12.53-0.16
QT Imaging$4.00M14.73-$4.03MN/AN/A

Summary

QT Imaging beats Allurion Technologies on 8 of the 13 factors compared between the two stocks.

Get Allurion Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALUR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALUR vs. The Competition

MetricAllurion TechnologiesMED PRODUCTS IndustryMedical SectorNYSE Exchange
Market Cap$15.37M$10.94B$6.23B$22.00B
Dividend YieldN/A1.87%5.74%3.61%
P/E Ratio-0.1620.3929.1532.73
Price / Sales0.4827.88587.2591.60
Price / CashN/A25.0537.5124.48
Price / Book-0.073.4912.324.67
Net Income-$7.20M$208.83M$3.32B$1.02B
7 Day Performance-3.74%-1.92%0.71%-0.31%
1 Month Performance-11.76%0.07%7.25%-0.17%
1 Year Performance-89.33%-8.95%61.89%11.29%

Allurion Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALUR
Allurion Technologies
2.0407 of 5 stars
$1.98
-0.5%
$9.25
+366.9%
-88.6%$15.37M$32.11M-0.16501
QTI
QT Imaging
N/A$2.25
+0.9%
N/A+223.9%$61.05M$4.00M0.00N/APositive News
DXR
Daxor
3.9651 of 5 stars
$12.88
+2.1%
$25.00
+94.1%
+48.3%$60.99MN/A0.0037News Coverage
Gap Up
ICCM
IceCure Medical
2.209 of 5 stars
$0.84
-3.1%
$2.64
+212.3%
+44.9%$59.85M$3.29M-5.2760
MDAI
Spectral AI
1.6648 of 5 stars
$2.21
-0.9%
$3.50
+58.4%
+96.7%$59.61M$29.58M-3.2083
TELA
TELA Bio
2.2039 of 5 stars
$1.50
+2.7%
$4.50
+200.0%
-39.8%$57.84M$69.30M-1.34120
CTSO
Cytosorbents
1.7246 of 5 stars
$0.93
+1.6%
$5.50
+491.4%
-21.1%$57.48M$35.60M-5.47220
NEPH
Nephros
2.3264 of 5 stars
$5.34
-1.1%
$5.50
+3.0%
+236.8%$57.24M$14.16M44.5030
BDMD
Baird Medical Investment
N/A$1.57
-0.6%
N/A-48.7%$56.45MN/A0.00N/ANews Coverage
Short Interest ↑
SURG
SurgePays
2.103 of 5 stars
$2.70
+1.9%
$9.50
+251.9%
+53.2%$54.14M$60.88M-1.0840
SRTS
Sensus Healthcare
2.224 of 5 stars
$3.21
-2.1%
$8.00
+149.2%
-52.0%$53.92M$41.81M-53.5040

Related Companies and Tools


This page (NYSE:ALUR) was last updated on 10/22/2025 by MarketBeat.com Staff
From Our Partners